In clinical practice, suspicion of PC is typically based on a combination of prostate-specific antigen (PSA) testing, digital rectal examination (DRE), and imaging findings, with definitive diagnosis obtained via biopsy. The gene discussed is KLK3; the disease is pachyonychia congenita.